Evidence map›Paper›PMID 32862254›Full record

ArticleDiabetologia2020

Higher BMI is associated with smaller regional brain volume in older adults with type 2 diabetes.

Rebecca K West, Abigail Livny, Ramit Ravona-Springer, Barbara B Bendlin, Anthony Heymann, Derek Leroith, Xiaoyu Liu, Hung-Mo Lin, Hagit Hochner, Yechiel Friedlander and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Diabetologia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 25 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Stability in BMI over time is associated with a better cognitive trajectory in older adults.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2022
    Article
  18. Dietary Supplement ofDrug design, development and therapy · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Rebecca K WestDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA. rebecca.west@mssm.edu.ORCID 0000-0002-0950-5721
Abigail LivnyDiagnostic Imaging Division, Sheba Medical Center, Ramat Gan, Israel.ORCID 0000-0003-2216-7357
Ramit Ravona-SpringerThe Joseph Sagol Neuroscience Center, Sheba Medical Center, Ramat Gan, Israel.ORCID 0000-0002-6440-3322
Barbara B BendlinDepartment of Medicine, University of Wisconsin, Madison, WI, USA.ORCID 0000-0002-0580-9875
Anthony HeymannSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.ORCID 0000-0003-2353-9933
Derek LeroithDepartment of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0003-0565-1753
Xiaoyu LiuDepartment of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0003-3723-5711
Hung-Mo LinDepartment of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0003-3176-6570
Hagit HochnerBraun School of Public Health, Hebrew University of Jerusalem, Jerusalem, Israel.ORCID 0000-0002-8853-2276
Yechiel FriedlanderBraun School of Public Health, Hebrew University of Jerusalem, Jerusalem, Israel.ORCID 0000-0001-6783-3531
Ithamar GanmoreThe Joseph Sagol Neuroscience Center, Sheba Medical Center, Ramat Gan, Israel.ORCID 0000-0003-3760-680X
Amir TiroshSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.ORCID 0000-0003-2210-5906
Michal Schnaider BeeriDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0002-4254-9742
Tel Aviv University · ILIcahn School of Medicine at Mount Sinai · USHebrew University of Jerusalem · ILSheba Medical Center · ILUniversity of Wisconsin–Madison · US

Funding

Wisconsin Alzheimer's Disease Research CenterP30AG062715 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI Sanjay Asthana · 2019 to 2026
$34.5M
Research Education ComponentP30AG066514 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Margaret Sewell · 2020 to 2026
$31.0M
Translational Research CoreP30DK020541 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI STREAMSON C CHUA · 2015 to 2026
$27.7M
QUANTITATIVE ANALYSIS OF MICROVASCULAR CHANGES IN THE AGING BRAINP01AG002219 · NIA · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI HAROUTUNIAN, VAHRAM · 1985 to 2009
$19.2M
Systemic and dietary advanced glycation end products in type 2 diabetes-related cognitive decline and incident dementia: effects on Alzheimer's pathology and cerebrovascular diseaseR01AG061093 · NIA · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI SCHNAIDER BEERI, MICHAL · 2019 to 2024
$4.3M
Peripheral and brain levels of advanced glycation end products AGEs and incident Alzheimers disease and neuropathologyR01AG053446 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SCHNAIDER BEERI, MICHAL, URIBARRI, JAIME · 2016 to 2021
$3.8M
Inflammation, long-term diabetes characteristics, and cognitive declineR01AG034087 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SCHNAIDER BEERI, MICHAL · 2009 to 2014
$3.7M
Hyperbaric oxygen therapy for cognition in diabetic elderly at high dementia riskR01AG051545 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SANO, MARY, SCHNAIDER BEERI, MICHAL · 2016 to 2021
$3.7M
NIA NIH HHS P01 AG002219NIA NIH HHS P30 AG062715NIA NIH HHS P30 AG066514NIA NIH HHS R01 AG034087NIA NIH HHS R01 AG051545NIA NIH HHS R01 AG053446NIA NIH HHS R01 AG061093NIDDK NIH HHS P30 DK020541
6 · The paper itself

Abstract

aims/hypothesisThere are established relationships between adiposity (obesity) and higher dementia risk, faster cognitive decline and associated neural injury. Type 2 diabetes is strongly linked to greater adiposity and has been consistently associated with neural injury and poor cognitive outcomes. However, although obesity is a major cause of type 2 diabetes, there is limited evidence on the association of adiposity with brain atrophy among individuals with type 2 diabetes.

methodsWe examined the association of BMI (a measure of adiposity), and of long-term trajectories of BMI (three empirically identified groups of trajectories-'normal', 'overweight' and 'obese'-using SAS macro PROC TRAJ), with regional brain volume, in a sample of older individuals (aged 64-84) with type 2 diabetes participating in the Israel Diabetes and Cognitive Decline Study (n = 198).

resultsUsing linear regression, we found that greater BMI was associated with smaller volumes of the inferior frontal gyrus (IFG) (r = -0.25, p = 0.001) and the middle temporal gyrus (r = -0.19; p = 0.010) after adjusting for sociodemographic covariates and total intracranial volume. In addition, there were significant differences between BMI trajectory groups in IFG volume (F = 4.34, p = 0.014), such that a long-term trajectory of obesity was associated with a smaller volume. Additional adjustment for cardiovascular and diabetes-related potential confounders did not substantively alter the results. There were no associations of adiposity with superior frontal gyrus, middle frontal gyrus or total grey matter volumes. CONCLUSIONS/

interpretationIn older adults with type 2 diabetes, long-term adiposity may have a detrimental impact on volume of brain regions relevant to cognitive functioning. Further studies to identify the underlying mechanisms are warranted. Graphical abstract.

Indexed as

Body Mass IndexBrainDiabetes Mellitus, Type 2Gray MatterHumansMagnetic Resonance ImagingObesityAdiposityBMIBrain volumeCognitive functioningInferior frontal gyrusMiddle temporal gyrusType 2 diabetes

Identifiers

PMID32862254
PMCPMC7530092
OpenAlexW3082405258

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.